pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·7h ago·1 min read
save

Aon warns 2027 will bring steep rise in employer health premiums, highlighting data gaps for public-sector plans

Aug 24, 2026·read at STAT ↗Negative

Aon’s chief actuary warned that 2026 data points to a harsh 2027 for employer-sponsored health insurance premiums, with costs expected to rise sharply.

The firm said employers will need better data and deeper insights to pinpoint where expenses are increasing, a call that comes as Aon has faced criticism for limiting data access to its clients.

The warning especially affects public-sector health plans, which traditionally rely on stable benefits, and could pressure government employers and unions as they negotiate coverage in the coming years.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: Public-sector purgatory, and a union-hospital fight”

read at STAT ↗
478 words · retrieved 6h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
RISING
topics
Gene Therapy (AAV)Oncology

related stories

  • 3d agoSTAT+: Up and down the ladder: The latest comings and goingsSTAT
  • Aug 11IRBs have a problem. Can North Star’s nonprofit model save it?STAT
  • Aug 10From ex vivo to in vivo: Shaping the next generation of viral vector manufacturingBioSpace
  • Jun 5STAT+: Up and down the ladder: The latest comings and goingsSTAT
  • May 13U.S. overdose deaths fell again in 2025, but some worry about policy and drug supply changesSTAT